Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04612829
Other study ID # NUTRIN002
Secondary ID
Status Completed
Phase Phase 2/Phase 3
First received
Last updated
Start date August 23, 2017
Est. completion date October 15, 2017

Study information

Verified date October 2020
Source Nutrin GmbH
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A thraot infection sometimes called pharyngitis can be either a bacterial or a viral infection leading to inflammation of the tissues of the throat that causes redness, pain and swelling of the walls and structure of the throat. The throat or Pharynx is the tube like structure that carries both food to the oesophagus and air to your wind pipe (called the larynx). Infective agents of the throat most often enters through the month or nose. Many of these infections are viral, other can be caused by bacteria such as Streptococcus Pyogenes, or Group A streptococcus. Symtoms of throat infections most commonly includes pain and a sensation of heat in the throat or Pharynx. Viral infections accounts for approx. 70% of all pharyngitis. Rhinovirus is the most common cause of viral infections. The other common causes of viral infections in descending order are corona virus, adeno virus, para influenza, and influenza virus. Viral infections are more common during the winter month with the exception of adeno viruses which occur year round. Viral Pharyngitis is spread through similar mechanism as other viral infections. Hand to mouth contact, contact with oral secretions, and sharing common utensils, all contributes to viral spread. Prevention of the spread of diseases is based on frequent hand washing, and clinical symptoms of different viruses are more prevalent during certain seasons. Coryza, conjectivitis, malease, or fatigue, hoarseness, and low grade fever such as the presence of viral phayngitis. Subjects with viral pharyngitis can also have atypical symptoms such as mouth breathing, nausea, abdominal pain, and diarrhoea. Medistus Antivirus is a medical device product with a noble impact. Kistosyn 100 extract contains polyphenols, and with the help of gum arabic, it forms a protective film over the mouth and throat mucus membranes. This protective Barrier lead to a physical (mechanical) barrier against viruses and bacteria which prevent their penetration into body cells, and their further propagation. Due to this physical effect, resistance development is not possible.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date October 15, 2017
Est. primary completion date October 15, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Patient with mild to moderate acute Pharyngitis or sore throat or strep throat - Voluntarily signed informed consent for participation in this clinical study - Compliance by the patient seems guaranteed, and the patient seems to be able to understand and complete the patient diary. Exclusion Criteria: - Severe respiratory tract infection (pneumonia, bronchitis or laryngitis) - Oro-pharyngeal paresthesia or mycosis - Severely traumatised and/or very severe oromucosal inflammation - Tonsillopharyngectomy - Peritonsillar abscess - Long term use (= 3 times per week within the last month or regular intake within the last 3 months before randomisation) of antiinflammatory drugs- Any long-acting or slow release analgesic intake including NonSteroidal Anti-Inflammatory Drugs(NSAIDs)within 24 hours before randomisation (e.g. piroxicam or naproxen) - Any anti-inflammatory drugs intake by systemic route within 12 hours before assigning - Any paracetamol intake within 6 hours before randomisation - Any cold medication (decongestant, antihistamine, expectorant, antitussive) within 6 hours before randomisation - Any topical throat medication intake containing or not a local oral anaesthetic such as lozenge, spray, mouth rinse within 4 hours before recruitment - Heavy smokers (>20 cigarettes/day)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Medistus Antivirus Lozenges
A blend of Kistosyn Extract with Gum Arabic

Locations

Country Name City State
India Arogyam Superspeciality Hospital Nagpur Maharashtra

Sponsors (1)

Lead Sponsor Collaborator
Nutrin GmbH

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Primary To assess the cough episodes count data collection on visit 2 from the subject for improvement in cough count 5 days
Primary Throat pain assessment on severity scale of 0-4 5 days
Primary Redness of throat on severity scale of 0-4 5 days
Primary Swelling assessment on severity scale of 0-4 5 days
See also
  Status Clinical Trial Phase
Recruiting NCT04083417 - Sore Throat in Primary Care - a Comparison of Phenoxymethylpenicillin and no Antibiotic Treatment Phase 4
Not yet recruiting NCT03517215 - The Development and Testing of a Scaling Strategy for a Community-Based Primary Care Antimicrobial Stewardship Program N/A
Not yet recruiting NCT01782183 - Thermographic Characteristics of Sore Throat by Thermographic Camera N/A
Completed NCT02608788 - S.L. Spray Solution® and Difflam® and Acular®Spray for the Prevention of Postoperative Sore Throat Phase 4
Completed NCT01986361 - Placebo-Controlled Onset-of-Action Study of Flurbiprofen Utilizing the Double-Stopwatch Method Phase 3
Completed NCT01118533 - Impact of Blades Used for Scheduled Orotracheal Intubation on Postoperative Sore Throat N/A
Completed NCT03397797 - Effect of Intraoperative Neuromuscular Blockade on Postoperative Sore Throat and Hoarseness
Completed NCT03282045 - Efficacy and Safety of the Lysobact Complete Spray®, Tantum Verde® and Pharyngal® Oromucosal Spray in the Treatment of Acute Sore Throat Phase 3
Completed NCT01902641 - Muscle Relaxation for Short Procedures N/A
Completed NCT01444703 - Comparison of Licorice Versus Sugar-water Gargle for Prevention of Postoperative Sore Throat and Postextubation Coughing N/A
Completed NCT00957996 - Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza Phase 3
Completed NCT01033799 - Effect of the Consumption of a Fermented Milk on Common Infections in Shift-workers N/A
Completed NCT05069844 - Preoperative Gum Chewing for Different Durations to Prevent Sore Throat After Endotracheal Intubation N/A
Completed NCT05247333 - Implementation of a Minor Ailment Service in Community Pharmacy Practice N/A
Recruiting NCT03369132 - Efficacy of Natural Seawater Based Throat Spray in Acute Sore Throat Relief N/A
Completed NCT02682134 - Sore Throat Prevention Following Intubation Phase 4
Terminated NCT00958776 - A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza Phase 3
Completed NCT00242281 - APC-111 MP Tablet Once a Day vs.Penicillin VK Four Times a Day Both for 10 Days in Patients With Strep Throat Phase 3
Completed NCT03729973 - Comparing Efficacy Preoperative Nebulized: Ketamine , Mgspo4 ,and Lidocaine In Attenuating Endotracheal Sore Throat Phase 3
Completed NCT04085744 - A Comparison Of Local Anesthetic Agents And Steroid On Tracheal Tube Cuff N/A